IgA Vasculitis with necrotizing arteritis: a multicenter retrospective study from the French Vasculitis Study Group and systematic review of the literature.

AutoimmunityMay 26, 2026 (epub)
Clinical ResearchRheumatology

Emmanuel Ribereau-Gayon, Amélie Carbonnelle-Puscian, Marie Ottavi et al.

✦ AI-curated · Sources linked

In 30 seconds

This multicenter retrospective study examined 30 patients with IgA vasculitis and necrotizing arteritis (IgAV-NA) to characterize its clinical features and compare them with classical IgA vasculitis and polyarteritis nodosa. IgAV-NA was associated with significantly higher rates of multi-organ involvement and mortality compared to classical IgA vasculitis.

Key findings

  • IgAV-NA patients had a median age of 54.5 years.
  • IgAV-NA showed significantly higher rates of multi-organ involvement and mortality compared to classical IgAV.
  • Compared to polyarteritis nodosa, IgAV-NA had less fever and neuropathy.

Why it matters

Understanding the distinct clinical features of IgAV-NA is crucial for timely diagnosis and management, as it presents with severe manifestations that may require intensified immunosuppression and vascular imaging.

Source

Published in Autoimmunity. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Rheumatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.